Hotline:
+ 49 (0) 2204 2918806

Market studies for category X

Items 1 to 10 of 528 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 53
  1. Net price*
    Year
  2. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Antyra, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    21 pages
    Global Markets Direct’s pharmaceuticals report, “Antyra, Inc. - Product Pipeline Review - 2013” provides data on the Antyra, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built
    Englisch | Zukunftsanalyse | SKU: 355041
  3. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Bridge Bioresearch Plc - Product Pipeline Review - 2013

    Global Markets Direct
    24 pages
    Global Market Direct’s pharmaceuticals report, “Bridge Bioresearch Plc - Product Pipeline Review - 2013” provides data on the Bridge Bioresearch Plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. T
    Englisch | Zukunftsanalyse | SKU: 354753
  4. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Hypertension - Pipeline Review, H2 2013

    Global Markets Direct
    236 pages
    Global Markets Direct’s, 'Hypertension - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players inv
    Englisch | Zukunftsanalyse | SKU: 355105
  5. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2013

    Global Markets Direct
    71 pages
    Global Markets Direct’s, 'Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Spinal Muscular Atrophy (SMA), complete with latest updates, and special features on late-stage and discontinued project
    Englisch | Zukunftsanalyse | SKU: 354817
  6. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Influenza - Pipeline Review, H2 2013

    Global Markets Direct
    264 pages
    Global Markets Direct’s, 'Influenza - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Influenza, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved
    Englisch | Zukunftsanalyse | SKU: 355169
  7. $2,000.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Follicular Lymphoma - Pipeline Review, H2 2013

    Global Markets Direct
    149 pages
    Global Markets Direct’s, 'Follicular Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Follicular Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews k
    Englisch | Zukunftsanalyse | SKU: 354881
  8. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    NewLink Genetics Corporation - Product Pipeline Review - 2013

    Global Markets Direct
    39 pages
    Global Markets Direct’s pharmaceuticals report, “NewLink Genetics Corporation - Product Pipeline Review - 2013” provides data on the NewLink Genetics Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorman
    Englisch | Zukunftsanalyse | SKU: 354945
  9. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Genocea Biosciences, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    22 pages
    Global Markets Direct’s pharmaceuticals report, “Genocea Biosciences, Inc. - Product Pipeline Review - 2013” provides data on the Genocea Biosciences, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant proj
    Englisch | Zukunftsanalyse | SKU: 355009
  10. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Logical Therapeutics, Inc. - Product Pipeline Review - 2013

    Global Markets Direct
    22 pages
    Global Market Direct’s pharmaceuticals report, “Logical Therapeutics, Inc. - Product Pipeline Review - 2013” provides data on the Logical Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant pro
    Englisch | Zukunftsanalyse | SKU: 354720
  11. $1,500.00
    2013
    Für diese Studie liegt keine Bewertung vor.

    Resolvyx Pharmaceuticals, Inc - Product Pipeline Review - 2013

    Global Markets Direct
    23 pages
    Global Markets Direct’s pharmaceuticals report, “Resolvyx Pharmaceuticals, Inc - Product Pipeline Review - 2013” provides data on the Resolvyx Pharmaceuticals, Inc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dorm
    Englisch | Zukunftsanalyse | SKU: 355073

Items 1 to 10 of 528 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 53